Search results
Results from the WOW.Com Content Network
In April 2006, the company acquired eight early phase clinical pharmacology sites from Radiant Research for $65 million. [ 19 ] [ 20 ] [ 21 ] In June 2006, it acquired Signet Laboratories, a provider of monoclonal antibodies used in the research of cancer, infectious disease, and neurodegenerative disease, for $8.95 million.
The endpoint clinical segment provides solutions to biopharmaceutical and contract research customers in serving complex and late-stage clinical trials. Fortrea's patient access business provides ...
IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services.
The DRKS is an open access, free of charge online register for clinical trials and is available both in English and German. DRKS is part of the WHO's ICTRP. The DRKS works with two partner registries in Germany, DeReG (German Registry for Somatic Gene-Transfer Trials) and Clinical Trial Registry of the University Medical Center Freiburg. [4]
Popular drugs for diabetes and weight loss could have an unexpected side effect.. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were ...
A total of 73 children, ages 4 to 14, were originally entered in the trial, which was sponsored and funded by the National Institute of Allergy and Infectious Diseases. Of the 73, 38 were randomly ...
The University of Texas Southwestern Medical Center (UT Southwestern or UTSW) is a public academic health science center in Dallas, Texas.With approximately 23,000 employees, [3] more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.
In clinical trials, the non-opioid medication received high patient satisfaction ratings, with 83% reporting "good" to "excellent" pain relief in real-world applications, Cheng noted.